News | EP Lab | January 07, 2022

Khaldoun Tarakji Joins Medtronic as Vice President and Chief Medical Officer of Cardiac Ablation Solutions

Khaldoun Tarakji is moving from Cleveland Clinic to Medtronic.

January 7, 2022 — Khaldoun Tarakji, M.D., M.P.H., associate section head of cardiac electrophysiology at the Heart, Vascular, and Thoracic Institute at Cleveland Clinic, has joined Medtronic as the vice president and chief medical officer (CMO) of the Cardiac Ablation Solutions (CAS) Operating Unit at Medtronic.

Tarakji will provide senior level medical expertise, strategic planning and guidance on evidence development, and objective medical and patient safety oversight to ensure technology and therapy effectiveness throughout the product lifecycle. He assumes the role previously held by Rob Kowal, M.D., Ph.D., chief medical officer.

“I am excited to be joining this organization at such a critical juncture in healthcare technology. Never before have we seen such an emphasis on novel technologies to drive improved patient outcomes for arrhythmias,” Tarakji said. “This Medtronic team of engineers and clinical leaders are innovating technologies that are truly advancing care for those suffering from the crippling effects of atrial and ventricular arrhythmias, and I’m excited to support the delivery and access of those therapies. I am also incredibly grateful to the physician and nurse partners of whom I’ve had the pleasure of working alongside during my tenure at Cleveland Clinic, and I look forward to collaborating together again in the future. Most importantly, I am forever grateful to all the patients who entrusted me with their most precious asset, and I hope I continue to serve them on a wider scale in my new role.”

With more than a decade-long career as a cardiac electrophysiologist (EP) at Cleveland Clinic, Tarakji is also a leader in digital health, helping to pioneer cardiovascular patient care via smart device, including remote patient monitoring. He is the founder of the Heart, Vascular & Thoracic Institute Center for Digital Health Technologies and leads a multidisciplinary team of medical experts in exploring and evaluating the potential impact of personal, digital technology to clinical practice. Tarakji holds the roles of associate professor of medicine at Cleveland Clinic Lerner College of Case Western University and director of the Center for International Medical Education at Cleveland Clinic. 

“We are thrilled to welcome Dr. Tarakji to Medtronic,” said Rebecca Seidel, president of the cardiac ablation solutions business, which is part of the cardiovascular portfolio at Medtronic. “Dr. Tarakji is a world-class physician and thought leader in the advanced treatment of atrial fibrillation and other arrhythmias. He’s a long-time advisor and clinical investigator for Medtronic and we are honored that he will be working with us to provide advanced cardiac mapping and ablation solutions for arrhythmia management.”

Watch a recent interview with Dr. Tarakji in the VIDEO: Antibacterial Envelope for EP Devices Reduced Infections in Patients With Hemotomas by 82 Percent.

Find more electrophysiology news and video

 


Related Content

News | EP Lab

Jan. 28, 2026 — Corify Care has announced a major development in cardiac electrophysiology with the publication of its ...

Home January 29, 2026
Home
News | EP Lab

April 22, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients ...

Home April 29, 2025
Home
News | EP Lab

April 21, 2025 — Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, will ...

Home April 21, 2025
Home
News | EP Lab

Feb. 12, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients ...

Home February 14, 2025
Home
News | EP Lab

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 31, 2024
Home
News | EP Lab

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
News | EP Lab

June 25, 2024 — Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) and GE HealthCare (announced HHNM as the ...

Home June 25, 2024
Home
News | EP Lab

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
News | EP Lab

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
Subscribe Now